Abstract

IMPACT OF ONGOING CO-MORBIDITY'S IN MUSCULOSKELETAL DISORDER MANAGEMENT

Radhika Sanivarapu*, Anitha Pendyala, Vishnu Priya Mallela, Ananda Vaishnavi Petla, Sharoni Bhuvanagiri

ABSTRACT

Co-morbidities frequently accompany musculoskeletal diseases (MSDs), and these factors have a substantial impact on the therapy and prognosis of MSDs. An overview of the implications of persistent co-morbidities on MSD care is given in this abstract. Initially, co-morbidities provide difficulties for diagnosis as they might conceal or mimic symptoms of multiple sclerosis, which can delay an accurate diagnosis and the start of a suitable treatment plan. Second, the existence of co-morbidities affects treatment choices, affecting things like drug interactions, exclusions, and customized therapy regimens. Thirdly, co-morbidities frequently make symptoms worse and negatively impact functional results for people with multiple sclerosis, thus addressing both illnesses at the same time requires specialized therapies. Furthermore, co-morbidities lead to increased rates of complications, longer hospital stays, and the requirement for interdisciplinary treatment, all of which raise healthcare consumption and expenditures. In order to optimize the therapy and improve the outcomes for patients with MSDs, it is imperative to comprehend the influence of concurrent co-morbidities. This underscores the necessity of comprehensive and integrated healthcare strategies in clinical practice.

Keywords: Musculoskeletal diseases, Comorbidities, Pain, Management, Quality of life.